We are thrilled to announce that binx health has successfully raised $65 million in a recent funding round, marking a significant milestone in our mission to redefine healthcare accessibility and convenience. binx health is at the forefront of creating innovative healthcare solutions that cater to the modern consumer's needs by offering on-demand, point-of-care testing where it is most needed. Our proprietary io庐 platform delivers fast PCR-based results鈥攃apable of testing for up to 24 different pathogens鈥攆rom sample-in to answer in approximately 30 minutes, shattering the traditional multi-day turnaround time for central lab testing. This investment will enable us to accelerate the development of our cutting-edge suite of offerings aimed at enhancing healthcare access in retail clinics, supermarkets, primary care offices, and homes. With a strong backing from esteemed investors, including Johnson & Johnson Innovation, Novartis Venture Fund, and others, we are poised to expand our presence and further innovate our mobile and digital healthcare solutions. Our operations span globally with key locations in Boston, MA, and Bath, UK, ensuring that we are well-positioned to meet healthcare needs wherever people live, work, and shop. This funding is not just a testament to our journey thus far, but a leap forward into a future where convenient and accessible healthcare is a reality for everyone. For more information about our offerings, visit www.mybinxhealth.com.







